153 related articles for article (PubMed ID: 37213278)
1. Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis.
Sun H; Liu Y; Zhang Y; Wang Y; Zhao Y; Liu Y
Front Oncol; 2023; 13():971435. PubMed ID: 37213278
[TBL] [Abstract][Full Text] [Related]
2. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer.
Hidaka H; Higashimoto K; Aoki S; Mishima H; Hayashida C; Maeda T; Koga Y; Yatsuki H; Joh K; Noshiro H; Iwakiri R; Kawaguchi A; Yoshiura KI; Fujimoto K; Soejima H
Clin Epigenetics; 2018 Dec; 10(1):150. PubMed ID: 30509319
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation of
Liu X; Bi H; Ge A; Xia T; Fu J; Liu Y; Sun H; Li D; Zhao Y
Transl Cancer Res; 2019 Sep; 8(5):1985-1996. PubMed ID: 35116947
[TBL] [Abstract][Full Text] [Related]
5. Methylation of three genes encoded by X chromosome in blood leukocytes and colorectal cancer risk.
Tian T; Bi H; Zhang D; Liu Y; Sun H; Jia C; Zheng T; Huang H; Fu J; Zhu L; Zhao Y
Cancer Med; 2021 Jul; 10(14):4964-4976. PubMed ID: 34145793
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor gene methylation related to colorectal cancer risk.
Xia T; Sun H; Huang H; Bi H; Pu R; Zhang L; Zhang Y; Liu Y; Xu J; Onwuka JU; Liu Y; Cui B; Zhao Y
Endocr Connect; 2019 Jul; 8(7):979-987. PubMed ID: 31176300
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA MALAT1 and Colorectal Cancer: A Propensity Score Analysis of Two Prospective Cohorts.
Li H; Zhang Y; Liu Y; Qu Z; Liu Y; Qi J
Front Oncol; 2022; 12():824767. PubMed ID: 35558512
[TBL] [Abstract][Full Text] [Related]
9. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk.
Bi H; Liu Y; Pu R; Xia T; Sun H; Huang H; Zhang L; Zhang Y; Liu Y; Xu J; Rong J; Zhao Y
Dig Dis Sci; 2019 Aug; 64(8):2158-2166. PubMed ID: 30815821
[TBL] [Abstract][Full Text] [Related]
10. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L; Balaguer F; Toiyama Y; Egoavil C; Rojas E; Guarinos C; Andreu M; Llor X; Castells A; Jover R; Boland CR; Goel A
PLoS One; 2014; 9(8):e104285. PubMed ID: 25127039
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive ceRNA network analysis and experimental studies identify an IGF2-AS/miR-150/IGF2 regulatory axis in colorectal cancer.
Liu B; Liu Y; Zhou M; Yao S; Bian Z; Liu D; Fei B; Yin Y; Huang Z
Pathol Res Pract; 2020 Oct; 216(10):153104. PubMed ID: 32853944
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis.
Baba Y; Nosho K; Shima K; Huttenhower C; Tanaka N; Hazra A; Giovannucci EL; Fuchs CS; Ogino S
Gastroenterology; 2010 Dec; 139(6):1855-64. PubMed ID: 20682317
[TBL] [Abstract][Full Text] [Related]
14. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
Ito Y; Koessler T; Ibrahim AE; Rai S; Vowler SL; Abu-Amero S; Silva AL; Maia AT; Huddleston JE; Uribe-Lewis S; Woodfine K; Jagodic M; Nativio R; Dunning A; Moore G; Klenova E; Bingham S; Pharoah PD; Brenton JD; Beck S; Sandhu MS; Murrell A
Hum Mol Genet; 2008 Sep; 17(17):2633-43. PubMed ID: 18541649
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer.
Zhang Y; Zhang L; Sun H; Liu Y; Xu J; Huang H; Fu J; Zhang D; Tian T; Zhao Y; Wang G
Mol Med; 2021 Sep; 27(1):114. PubMed ID: 34544358
[TBL] [Abstract][Full Text] [Related]
16. Differential DNA methylation analysis of
Su JQ; Lai PY; Hu PH; Hu JM; Chang PK; Chen CY; Wu JJ; Lin YJ; Sun CA; Yang T; Hsu CH; Lin HC; Chou YC
World J Gastroenterol; 2022 Feb; 28(8):825-839. PubMed ID: 35317099
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
Ghatak S; Satapathy SR; Sjölander A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and potential drug target of O6-methylguanine-DNA methyltransferase in colorectal cancer: a meta-analysis.
Zheng CG; Jin C; Ye LC; Chen NZ; Chen ZJ
Tumour Biol; 2015 Aug; 36(8):5839-48. PubMed ID: 25716203
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
[TBL] [Abstract][Full Text] [Related]
20. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
